Articles Tagged With: MRSA
-
Environmental Shedding of MRSA Far Greater Than From Multidrug-Resistant Gram-Negative Bacilli
An observational cohort study showed shedding of methicillin-resistant Staphylococcus aureus by colonized patients outside hospital rooms or during outpatient clinic visits occurred more often than in those colonized by multidrug-resistant gram-negative bacilli.
-
Environmental Shedding of MRSA Is Far Greater than from Multidrug-Resistant Gram-Negative Bacilli
An observational cohort study revealed shedding of methicillin-resistant Staphylococcus aureus by colonized patients outside hospital rooms or during outpatient clinic visits occurred more often than in those colonized by multidrug-resistant gram-negative bacilli.
-
Annual Costs of MDRO Infections: $5 Billion
With healthcare systems across the nation focused on the COVID-19 pandemic, other priorities have largely gone by the wayside, including the formidable and longstanding problem of multidrug-resistant organisms.
-
Antibiotic-Resistant Bugs Do Not Sleep During the Pandemic
Outbreaks with antibiotic-resistant pathogens are occurring in hospital COVID-19 units, primarily caused by multidrug-resistant organisms that are hard to eradicate from the patient environment, a Centers for Disease Control and Prevention investigator reports.
-
Does MRSA Nares Colonization Predict Non-Respiratory MRSA Infections?
Nares screening for methicillin-resistant Staphylococcus aureus (MRSA) carried a high negative predictive value to rule out MRSA infections at various sites.
-
Does MRSA Nares Colonization Predict Non-Respiratory MRSA Infections?
Nares screening for methicillin-resistant Staphylococcus aureus (MRSA) has a high negative predictive value to rule out MRSA infections at various sites.
-
Outcomes with Daptomycin Plus a β-Lactam Compared to Daptomycin Alone for MRSA Bacteremia
In a retrospective cohort study, investigators found the addition of a β-lactam antibiotic to daptomycin led to less clinical failure (60-day all-cause mortality and/or 60-day recurrence) in patients with methicillin-resistant Staphylococcus aureus bacteremia.
-
Infectious Disease Alert Updates
Let’s Not Shake on This; The Tricky Business of Treating Early Cocci; On-Site Rapid Detection of Bacteriuria
-
Empiric Anti-MRSA Therapy in Pneumonia May Not Always Be a Good Idea
In a retrospective cohort study, empiric anti-methicillin-resistant Staphylococcus aureus treatment was not associated with a reduction in mortality in any subgroup of patients studied and appeared to cause harm in many.
-
Evaluation of 2020 Vancomycin Guidelines: Highlights, Limitations, and Obstacles
The key change from the 2009 vancomycin guidelines is the switch from trough-based to area under the curve (AUC)-based dosing and monitoring. This article will highlight key differences between the 2009 and 2020 guidelines, limitations of the new guidelines, and implementation issues.